Zinc supplementation in patients with polycystic ovarian syndrome
Not Applicable
- Conditions
- Polycystic ovarian syndrome.Sclerocystic ovary syndrome Stein-Leventhal syndrome
- Registration Number
- IRCT138803212017N2
- Lead Sponsor
- 1) Vice-chancellor for research of Tabriz University of Medical Sciences 2)Tabriz Nutrition Researc
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Women with PCOS diagnosed by the Rotterdam consensus criteria (Presence of 2 of the following 3 conditions: i. Oligo/anovulation ii. clinical or biochemical evidence of hyperandrogenism iii. Polycystic ovaries on ultrasound examination), age 20-45 years, BMI = 25, moderate activity
Exclusion criteria: Any disease that influence metabolic parameters in this trial (liver, cardiovascular, kidney or gastrointestinal diseases, hypo/hyper thyroidism, hyperprolactinemia, congenital adrenal hyperplasia, Cushing’s syndrome, androgen secreting tumors), insulin consumption, receiving antihypertension drugs, pregnancy, breast feeding, receiving any vitamin or mineral supplements, any special diet.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Zinc serum value. Timepoint: Baseline and at the end of intervention. Method of measurement: atomic absorption spectrophotometry.
- Secondary Outcome Measures
Name Time Method